MEDIAN DIAGNOSTICS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,390 KRW | -0.08% |
|
-0.64% | -22.51% |
| 1 week | -0.64% | ||
| Current month | -0.80% |
| 1 day | -0.08% | ||
| 1 week | -0.64% | ||
| Current month | -0.80% | ||
| 1 month | -2.06% | ||
| 3 months | -18.49% | ||
| 6 months | -8.22% | ||
| Current year | -22.51% |
1 week
10 500.00
13 890.00
1 month
10 500.0013 890.00
Current year
10 500.0017 000.00
1 year
10 500.0025 950.00
3 years
10 500.0047 000.00
5 years
10 500.0063 000.00
10 years
10 500.0063 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jin-Sik Oh
CEO | Chief Executive Officer | 56 | - |
Chung-Su Park
DFI | Director of Finance/CFO | 49 | - |
Byeong-Il Yoon
AUD | Comptroller/Controller/Auditor | 57 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dong-Guel Kwak
BRD | Director/Board Member | 64 | - |
Jin-Sik Oh
CEO | Chief Executive Officer | 56 | - |
Ki-Hyun Yoon
BRD | Director/Board Member | 37 | - |
Median Diagnostics Inc. is a Korea-based company principally engaged in the manufacture and distribution of veterinary medicines. The Company in control of the technology include hybridoma cell fusion technology, monoclonal antibody bank, recombinant expression, lateral flow technology, stabilization technology and other veterinary medicine technology. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -22.51% | 15.74M | |
| -22.30% | 68.94B | |
| +18.88% | 3.43B | |
| -3.62% | 3.22B | |
| -2.87% | 1.46B | |
| -15.41% | 1.38B | |
| -4.30% | 1.26B | |
| -27.74% | 1.21B | |
| -13.54% | 1.14B | |
| -2.99% | 1.02B |
- Stock Market
- Equities
- A233250 Stock
